This prospective cross-sectional observational study aims to compare thoracolumbar fascia thickness between women with fibromyalgia and healthy female controls using ultrasonography. Thoracolumbar fascia thickness will be measured bilaterally at the L2-L3 and L4-L5 levels. Secondary analyses will evaluate the relationships between thoracolumbar fascia thickness and pain intensity, fibromyalgia-related functional impact, widespread pain, and symptom severity in participants with fibromyalgia.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Female sex
* Age between 18 and 65 years
* For the fibromyalgia group, diagnosis of fibromyalgia according to the 2016 revised American College of Rheumatology criteria
* For the healthy control group, absence of fibromyalgia or chronic widespread pain
* Willingness to participate and provision of written informed consent
Exclusion Criteria:
* Pregnancy
* Previous lumbar surgery or severe spinal deformity
* Active infection, malignancy, or systemic inflammatory disease
* History of trauma or surgery, or presence of a skin lesion at the ultrasonographic measurement site
* Inability to complete the study assessments or provide informed consent
Primary outcome measure(s)
Thoracolumbar Fascia Thickness — During the single study visit Thoracolumbar fascia thickness will be measured by ultrasonography bilaterally at the L2-L3 and L4-L5 interspinous levels, 2 cm lateral to the midline. Measurements will be recorded separately for the right and left sides at each level, and bilateral mean thickness values will also be calculated. Thoracolumbar fascia thickness will be compared between women with fibromyalgia and healthy female controls.
Trial sites (1)
Facility
City
Region
Status
Ankara Etlik City Hospital
Ankara
Ankara
Recruiting
More Diskapi Teaching and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.